58
nanotimes Patents
11-09 :: September 2011
Contact: TransMIT GmbH, Thomas Widmann, Kerkrader Str. 3, D-35394 Giessen, Germany, Phone: +49-(0)641- 94364-35 ht tp: / /www.hipo-onl
ine.de/uk/uk_download.
cfm?expose_Id=577&pdf_name=TM425_TM521_ TM612_Expose_EN_2011-09-06.pdf
New substances for the effective stimulation of natri- uretic peptide receptors are presented, which bind to the natriuretic peptide receptors A and B (NPR-A and NPR-B) due to their novel structure, thereby com- prising a significant advantage over already known receptor agonists (e.g. nesiritides).
This makes highly promising substances available for the development of pharmaceuticals, which promise significantly better effects while at the same time of- fering effective compatibility. The new substances are suitable to be utilised to treat the following diseases: congestive heart disease, coronary heart disease, organic and functional vascular disorders, nephro- tic syndrome, hypertension, myocardial infarction, erectile dysfunction, primary or secondary fibrosis, cirrhosis of the liver, pulmonary fibrosis. The sub- stances are also suitable to be used for improvements in arterial, venous and capillary blood flow.
TransMIT is looking for cooperation partners for the further preclinical and clinical development and approval of the new substances through to a pharmaceutical suitable for prescription in Europe, America and Asia.
Subharmonic Mixer for Electromagnetic HF Radiation in the THz Frequency Range
Abstract: The present subharmonic frequency mixer is used to generate a mixed signal from frequencies in the submillimeter and the terahertz wavelength. Based on standards of the semiconductor technology, this new mixer achieves an extra high mixing efficiency due to operating above the transistor cutoff frequency.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67